RARB and metastatic neoplasm: High levels of RARα, RARβ, RXRα and RXRβ show a significant association with stage IV tumors, “de novo” metastatic disease, microsatellite-stable-status, epithelial-to-mesenchymal-transition, as well as PIK3CA and TP53 expression.